96736 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 5 to 11 amino acids
NEUROPROTECTIVE COMPOSITION AND METHOD OF USE
#3302Method and pharmaceutical composition for use in the treatment of cancer
#3303MULTIVALENT PEPTOID OLIGOMERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING SAME
#3304V1a receptor agonists
#3305Recombinant polypeptide construct comprising circumsporozoite protein HLA class I restricted T-cell epitopes
#3306Immunotherapy against several tumors including neuronal and brain tumors
#3307Personalized immunotherapy against several neuronal and brain tumors
#3308Highly immunogenic peptides derived from the human immunodeficiency virus V2 region
#3309αvβ6 peptide ligands and their uses
#3310MICROPEPTIDES AND USE THEREOF FOR MODULATING GENE EXPRESSION
#3311Melanocortin-1 receptor-specific linear peptides
#3312FUSION PEPTIDE AND USE THEREOF FOR CELL MEMBRANE PENETRATING
#3313Polymers containing multivalent amyloid-beta-binding D-peptides and their use
#3314Functionalized titanium binding peptides and implants coated with same
#3315Substrates and inhibitors of prolyl oligopeptidase and methods of use
#3316Peptide tyrosinase inhibitors and uses thereof
#3317Palladium catalyzed reactions executed on solid-phase peptide synthesis supports for the production of self-assembling peptides embedded with complex organic electronic subunits
#3318Small peptide specific for lung cancer and application thereof
#3319Method for producing a recombinant peptide and resultant peptide
#3320METHOD FOR INHIBITING INFLAMMATION and PRO-INFLAMMATORY CYTOKINE/CHEMOKINE EXPRESSION USING A GHRELIN ANALOGUE
#3321Extracellular matrix metalloproteinase inducer (EMMPRIN) peptides and binding antibodies
#3322Peptide agents for cancer therapy
#3323Peptide compositions
#3324Peptides derived from cytotoxicity receptor natural killer protein 44 NKP44
#3325Compositions and methods for the treatment of VprBP-related cancers
#3326COMPOSITIONS AND METHODS FOR TREATING PTSD AND RELATED DISEASES
#3327Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof
#3328Compounds for the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions
#3329Adjuvant compound
#3330HOUSE DUST MITE ALLERGEN
#3331IMMUNOGENIC WT-1 PEPTIDES AND METHODS OF USE THEREOF
#3332PEPTIDES THAT TARGET DORSAL ROOT GANGLION NEURONS
#3333Compounds which inhibit neuronal exocytosis
#3334Detection of degradative enzymes and biomolecules in bodily fluids
#3335Treatments for Gastrointestinal Disorders
#3336BUFFERED OPHTHALMIC COMPOSITIONS AND METHODS OF USE THEREOF
#3337Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo
#3338ZINC FINGER NUCLEASE FOR THE CFTR GENE AND METHODS OF USE THEREOF
#3339COMPOSITION
#3340COMPOSITIONS
#3341Modified coiled coil type proteins having improved properties
#3342Peptides for management of lactation
#3343Matrix Metalloproteinase Substrates And Other Cleavable Moieties And Methods Of Use Thereof
#3344PROCESS FOR THE MANUFACTURE OF CYCLIC UNDECAPEPTIDES
#3345Peptide-conjugated oligonucleotide therapeutic and method of making and using same
#3346Immunosuppression modulating compounds
#3347ANTIMICROBIAL PEPTIDES
#3348NOVEL INTEGRIN alpha9 beta1 LIGAND AND USES THEREOF
#3349Process for the Production of Bivalirudin
#3350Sustained-release composition and method for producing the same
#3351WT1 antigen peptide conjugate vaccine
#3352Amphiphilic peptides comprising the formula I: (XYXY), and uses thereof
#3353Cyclic RNA and protein production method
#3354Recombinant AAV capsid protein
#3355Synthetic peptides with a non-narcotic type of analgesic effect
#3356Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
#3357DPY-30 Binding Peptides
#3358COMPOSITION AND EXTERNAL APPLICATION FOR ACCELERATION OF MUSCLE DIFFERENTIATION AND IMPROVING OF MUSCLE MASS
#3359Peptide compounds that inhibit neuronal exocytosis
#3360Synthetic peptides capable of binding to influenza hemagglutinin protein
#3361PEPTIDES FOR THE TREATMENT OF CANCER
#3362EGFL7 targeting and/or binding polypeptides and methods for inhibiting angiogenesis
#3363Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases
#3364INHIBITING INTERACTION BETWEEN HIF-1ALPHA AND p300/CBP WITH HYDROGEN BOND SURROGATE-BASED HELICES
#3365VIP fragments and methods of use
#3366COMPOSITIONS AND METHODS FOR ANALYZING HISTIDINE PHOSPHORYLATION
#3367REAGENTS AND METHODS FOR DETECTING PROTEIN CROTONYLATION
#3368Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
#3369Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
#3370COMPOUND, USE AND METHOD
#3371Modulators for Sirt5 and assays for screening same
#3372Biotin-conjugated hexapeptide-2 derivative and use thereof
#3373Short designed peptides possessing selective actions against bacteria and cancer cells
#3374Peptides and peptidomimetics in combination uses and treatments for cancer patient subpopulations
#3375PEPTIDE MIMOTOPES TO OXIDATION SPECIFIC EPITOPES
#3376Peptidomimetic macrocycles
#3377Environmentally sensitive compositions and methods of use in the treatment and diagnosis of tumors
#3378Peptide increasing fusiogenic capacity of a gamete
#3379Modified kisspeptin peptides and uses thereof
#3380Stereoisomer peptides, their polymer conjugates, their encapsulation into nanoparticles, and uses thereof for the treatment of diseases caused by abnormal angiogenesis
#3381Antibodies to kallidin and des-Arg-kallidin
#3382Methods for preparing high throughput peptidomimetics, orally bioavailable drugs and compositions containing same
#3383Process for the synthesis of therapeutic peptides
#3384Native ligation process
#3385Fast dissolving pharmaceutical composition
#3386METHODS AND COMPOSITIONS FOR DETECTING ENDOMETRIAL OR OVARIAN CANCER
#3387Biologically active peptides
#3388Peptide having affinity for silicon nitride (SiN), and use therefor
#3389N-TERMINALLY MODIFIED OLIGOPEPTIDES AND USES THEREOF
#3390Organogels and emulsions for biological and non-biological applications
#3391COLLAGEN-BINDING SYNTHETIC PEPTIDOGLYCANS FOR WOUND HEALING
#3392COLLAGEN-BINDING SYNTHETIC PEPTIDOGLYCANS FOR USE IN VASCULAR INTERVENTION
#3393Niacin-peptide having skin whitening activity and use for same
#3394HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
#3395Peptide pharmaceuticals
#3396Growth hormone releasing peptides
#3397Macrocyclic compounds for suppressing replication of hepatitis C virus
#3398NEMO BINDING DOMAIN FUSION PROTEINS
#3399Microwave-assisted peptide synthesis
#3400Skin permeating and cell entering (SPACE) peptides and methods of use thereof
#3401Treatment of amyloidoses using myelin basic protein and fragments thereof
#3402Self-regulated peptide hydrogel for insulin delivery
#3403Thrombopoietic compounds
#3404Immunogenic compositions and methods
#3405Xenoantigen-Displaying Anti-Cancer Vaccines and Method of Making
#3406Modulation of activity of proneurotrophins
#3407SAA domain-specific antibodies and peptide antagonists and use thereof to treat inflammatory diseases
#3408Homing agents
#3409Inhibitors targeting human ghrelin O-acyltransferase
#3410Peptide C alpha-amides, methods for preparing same and uses thereof as precursors of peptide C alpha-thioesters for protein synthesis
#3411CHIMERIC POLYPEPTIDES AND THEIR USE
#3412Antitumor peptide and use thereof
#3413Methods for treating pain
#3414Structural mimetics of proline-rich peptides and use thereof
#3415ASSAY FOR DETERMINING RELATIVE REDOX CHANGES IN LIVING CELLS AND ASSOCIATED DEVICES, SYSTEMS, AND METHODS
#3416INTEGRIN INTERACTION INHIBITORS FOR THE TREATMENT OF CANCER
#3417Netrin loop peptide mimetics and uses thereof
#3418NEAR-INFRARED LIGHT-ACTIVATED PROTEINS
#3419CCR2 antagonist peptides
#3420Peptoid oligomers, pharmaceutical compositions and methods of using the same
#3421Compositions and methods for treating inflammation and fibrosis
#3422CRLF-2 BINDING PEPTIDES, PROTOCELLS AND VIRAL-LIKE PARTICLES USEFUL IN THE TREATMENT OF CANCER, INCLUDING ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
#3423AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#3424Amphiphilic peptides for treatment of keratitis
#3425METHOD OF TREATING AN ISCHEMIA-REPERFUSION INJURY-RELATED DISORDER BY ADMINISTERING GPCR LIGANDS
#3426Substrate-mimetic Akt inhibitor
#3427Method for producing multipolar cell
#3428Prion disease-specific epitopes and methods of use thereof
#3429Elastin digest compositions and methods utilizing same
#3430Compositions and methods for analyzing histidine phosphorylation
#3431Mirac proteins
#3432Stabilized formulations of peptides and proteins protecting against non-enzymatic degradation
#3433Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors
#3434Cytokine receptor peptides, compositions thereof and methods thereof
#3435Artificial signal peptide for expressing an insoluble protein as a soluble active form
#3436Methods and compositions related to targeting tumors and wounds
#3437Peptides and methods and uses thereof for preventing retinal disorders
#3438NUCLEIC ACIDS ENCODING PEPTIDES FOR TREATING WOUNDS, ANTI-ANGIOGENIC COMPOUNDS AND USES THEREOF
#3439Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof
#3440Amyloid β-protein-specific production-inhibiting polypeptide
#3441Peptides targeting receptor activator of nuclear factor-κB (RANK) and their applications
#3442Ligands to radiation-induced molecules
#3443SKIN OR HAIR BINDING PEPTIDES
#3444Method and pharmaceutical composition for hair growth
#3445Native and agonist CTL epitopes of the MUC1 tumor antigen
#3446Peptide compounds for inhibition of platelet aggregation
#3447Beta-arrestin effectors and compositions and methods of use thereof
#3448Organic compounds and their uses
#3449Inhibitors of Nox1
#3450Cationic peptides and use of such peptides for inhibiting exotoxin production
#3451Mirac proteins
#3452Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases
#3453Functional lipid constructs
#3454Methods for treating pain by administering peptides derived from human basic proline-rich lacrimal protein
#3455N-ACYLPEPTIDE DERIVATIVES AND THEIR USES
#3456Targeted antimicrobial moieties
#3457Real-time analysis for cross-linked peptides
#3458TCL1 peptides for immunotherapy
#3459SYNTHETIC PEPTIDES AND RANDOM COPOLYMERS FOR THE TREATMENT OF AUTOIMMUNE DISORDERS
#3460Kinase inhibitors and uses thereof
#3461COMPOSITION FOR IMPROVING BRAIN FUNCTION AND METHOD FOR IMPROVING BRAIN FUNCTION
#3462Nanoparticle-peptide compositions
#3463Peptides from chaperonin 60.1
#3464ANTAGONISTS FOR ABDOMINAL VASOPRESSIN V2 RECEPTOR AND USES THEREOF
#3465Synthetic peptides for treatment of bacterial infections
#3466Methods and compositions for tumor vaccination and therapy
#3467IAP BIR domain binding compounds
#3468Stabilized Peptide Helices For Inhibiting Dimerization Of Chemokine C Motif Receptor 2 (CCR2)
#3469β-arrestin effectors and compositions and methods of use thereof
#3470Modified mini-hepcidin peptides and methods of using thereof
#3471MODULATION OF GHRELIN LEVELS AND GHRELIN/UNACYLATED GHRELIN RATIO USING UNACYLATED GHRELIN
#3472ACTH prophylactic treatment of renal disorders
#3473Fluorescent substrates for determining lysine modifying enzyme activity
#3474INTESTINAL PEPTIDE TARGETING LIGANDS
#3475MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1
#3476Peptides and nanoparticles for therapeutic and diagnostic applications
#3477PEPTIDE INHIBITORS FOR MEDIATING STRESS RESPONSES
#3478Angiogenic active lytic peptides
#3479Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers
#3480Development of novel macromolecule transduction domain with improved cell permeability and method for using same
#3481SINGLE DOMAIN TDF-RELATED COMPOUNDS AND ANALOGS THEREOF
#3482Peptide inhibiting matrix metalloproteanases activity and use thereof
#3483Uses of peptides to treat brain injury and disease
#3484ANTAGONISTS OF MUC1
#3485Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
#3486Method of treating endometriosis
#3487Self-assembling peptides incorporating modifications and methods of use thereof
#3488Cyclin A1-targeted T-cell immunotherapy for cancer
#3489Peptides for Treating Alzheimers's Disease and Related Conditions
#3490Peptides for Progressive Treating Multi-Focal Leukoencephalopathy and Related Conditions
#3491Peptides for the Treatment of Multiple Sclerosis and Related Diseases
#3492RTEF-1 variants and the use thereof for inhibition of angiogenesis
#3493Fragments of p97 and uses thereof
#3494Activated collagen scaffold materials and their special fused active restoration factors
#3495Cyclin based inhibitors of CDK2 and CDK4
#3496Integrin-blocking polypeptides and uses thereof
#3497Synthesis of libraries of peptide tertiary amides
#3498Peptide preparations and peptides with antitumour activity
#3499Peptide compounds for suppressing inflammation
#3500Methods and products for treating preeclampsia and modulating blood pressure
#3501Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
#3502Binding Inhibitors of the Beta. Transducin Repeat-Containing Protein
#3503Activated collagen scaffold materials and their special fused active restoration factors
#3504IPNV-ISAV bivalent vaccine using a virus-like particle-based platform and methods of using the same
#3505DPP-4 inhibitor
#3506HEMIASTERLIN DERIVATIVES AND USES THEREOF IN THE TREATMENT OF CANCER
#3507ANTI-ANGIOGENIC PEPTIDES AND USES THEREOF
#3508NOVEL ANTIBACTERIAL AND FUNGICIDAL PEPTIDE IN WHICH LYSINE AND TRYPTOPHAN RESIDUES ARE REPEATED, AND USE THEREOF
#3509WNT family-derived peptides and use thereof
#3510PEPTIDE BINDING TO GRAPHITIC MATERIALS AND PHAGE INCLUDING SAME
#3511Inhibitors against endosomal/lysosomal enzymes
#3512Genes that increase plant oil and method for using the same
#3513Genes that increase plant oil and method for using the same
#3514Genes that increase plant oil and method for using the same
#3515Genes that increase plant oil and method for using the same
#3516SELECTIVE GPCR LIGANDS
#3517Antisense antiviral compound and method for treating influenza viral infection
#3518Methods and compositions for treating pain
#3519Cytotoxic T Lymphocyte Inducing Immunogens For Prevention Treatment and Diagnosis of INFLUENZA VIRUS INFECTION
#3520Vaccine
#3521PAT-LM1 epitopes and methods for using same
#3522Genes that increase plant oil and method for using the same
#3523Antagonist peptide of the bond between CD47 and a protein belonging to the thrombospondin family
#3524USE OF TIGHT JUNCTION ANTAGONISTS TO TREAT INFLAMMATORY BOWEL DISEASE
#3525Compositions and methods of use for cell targeted inhibitors of the Cystic Fibrosis transmembrane regulator associated ligand
#3526Peptide based inhibition of caPCNA interaction in cancer
#3527Oligodendrocyte Differentiation
#3528PROCESS FOR THE PREPARATION OF OCTREOTIDE ACETATE
#3529NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#3530ANTIVIRAL PEPTIDES EFFECTIVE AGAINST HEPATITIS C VIRUS
#3531NOVEL A4B7 PEPTIDE ANTAGONISTS
#3532TRANSCUTANEOUS DELIVERY OF THERAPEUTIC AGENTS
#3533Compounds binding to the bacterial beta ring
#3534IMMUNOGENIC EPITOPES OF NGEP ANTIGEN
#3535Agonists of guanylate cyclase and their uses
#3536Peptide-based compounds as inhibitors of neurotransmitter secretion
#3537ND2 peptides and methods of treating neurological disease
#3538Inhibitors of mitochondrial fission and methods of use thereof
#3539Compounds for control of appetite
#3540NOVEL ANTIVIRAL COMPOUNDS FROM MARINE EXTRACTS
#3541Vectors encoding a paralytic peptide
#3542Aqueous liquid composition
#3543Immunogenic epitopes for immunotherapy
#3544Immunologically active polypeptide
#3545HJURP peptides and vaccines including the same
#3546Multi-leu peptides and analogues thereof as selective PACE4 inhibitors and effective antiproliferative agents
#3547PEPTOID NEUTRALIZING AGENTS
#3548PEPTOID NEUTRALIZING AGENTS
#3549Compositions for treating glioma
#3550ANTI-AMYLOIDOGENIC, ALPHA-HELIX BREAKING ULTRA-SMALL PEPTIDE THERAPEUTICS
#3551Compositions and methods for augmenting permeability barriers
#3552Peptide-bound gold metal nano-clusters as cancer cell killing agents
#3553TOPK peptides and vaccines including the same
#3554RECOMBINANT HUMAN NAGLU PROTEIN AND USES THEREOF
#3555Absent and Rare Peptides and Therapeutic Uses Thereof
#3556BROAD SPECTRUM ANTIBIOTICS
#3557Leukemia stem cell targeting ligands and methods of use
#3558Quantification of vaccine compositions
#3559Peptide vaccines for cancers expressing tumor-associated antigens
#3560Peptide derivatives and use thereof as carriers for molecules in the form of conjugates
#3561Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation
#3562Methods and compositions for targeting adipose cells in mammals
#3563Arenavirus inhibiting peptides and uses therefor
#3564METHODS AND COMPOSITIONS FOR MODULATING THE Wnt PATHWAY
#3565Solid phase peptide synthesis via side chain attachment
#3566Peptide inhibitors of serotonin 5-HT2c receptors:PTEN interaction
#3567The use of HCV immunogenic peptide or a derivative thereof in the prevention or treatment of arthritis
#3568Antimicrobial peptides for treatment of infectious diseases
#3569Methods and products for in vivo enzyme profiling
#3570Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
#3571Inhibitors of beta integrin-G protein alpha subunit binding interactions
#3572Peptides that target dorsal root ganglion neurons
#3573Immunogenic compositions against human progastrin peptides
#3574Tubulysin compounds, methods of making and use
#3575Tubulysin compounds, methods of making and use
#3576Anti-RhoB antibodies
#3577PEPTIDES HAVING PROTECTIVE EFFECT TOWARDS THE INFLAMMATORY ACTIVITY OF PEPTIDE 31-43 OF A-GLIADIN IN CELIAC DISEASE
#3578A2M FRAGMENTS AND APPLICATIONS THEREOF
#3579Peptides that selectively home to heart vasculature and related conjugates and methods
#3580Binding molecules for human factor VIII and factor VIII-like proteins
#3581ACID-CLEAVABLE LINKERS EXHIBITING ALTERED RATES OF ACID HYDROLYSIS
#3582Methods of phosvitin extraction and phosphopeptide preparation from egg yolk
#3583Further novel anti-parasitic compounds
#3584Oligopeptide for treating liver fibrosis and/or treating hepatitis B and/or improving liver function
#3585Anti-microbial peptides and methods of use thereof
#3586Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer
#3587Lymphatic zip codes in tumors and pre-malignant lesions
#3588Amphiphilic peptides and hydrogel matrices thereof for bone repair
#3589Process For Extraction Of Peptides And Its Application In Liquid Phase Peptide Synthesis
#3590TEMPLATE-FIXED BETA-HAIRPIN PEPTIDOMIMETICS WITH PROTEASE INHIBITORY ACTIVITIY
#3591Methods for treatment of cancer by targeting Sirt5
#3592Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion
#3593RNA targeting compounds and methods for making and using same
#3594Compositions and methods for inducing an immune response
#3595Stable peptide-based PACE4 inhibitors
#3596Immunotherapeutic Methods Using Epitopes of WT-1 and GATA-1
#3597INFLUENZA NEUTRALIZING AGENTS
#3598TMEM22 PEPTIDES AND VACCINES INCLUDING THE SAME
#3599C1ORF59 PEPTIDES AND VACCINES INCLUDING THE SAME
#3600Aquaporin-4 peptide compositions and methods of use thereof